Robert H. Weiss' clinical interests include the diagnosis and treatment of all renal diseases and electrolyte problems. His research interests concern the cyclins and cyclin inhibitors, cancer growth control (kidney and breast cancer), metabolomics and proteomics, and polycystic kidney disease.
M.D., UC Irvine College of Medicine, Irvine, California, 1984
B.A., UC Santa Cruz, Santa Cruz, California, 1976
M.S., UCLA, Los Angeles, California, 1980
California-Pacific Medical Center, San Francisco, California, 1985-1987
University of California, San Francisco, San Francisco, California, 1991
American Board of Internal Medicine, 1987
American Board of Internal Medicine, Nephrology, 1996
American Association for the Advancement of Science
American College of Physicians
American Society of Nephrology
Select Recent Publications
Chen H, Li C, Huang j, Cung T, Seiss K, Beamon J, Carrington MF, Porter LC, Burke PS, Yang Y, Ryan BJ, Kiu R, Weiss RH, Preyra F, Cress WD, Brass AL, Rosenberg ES, Walker BD, Yu XG, Lichterfeld M. CD4 T cells from elite controllers resist HIV-1 infection by selective upregulation of p21 cip-1/waf-1. Journal of Clinical Investigation. 2011 Apr 1;1214:1549-60.
Kim K, Taylor SL, Ganti S, Guo L, Osier M, Weiss RH. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer, Omics., 2011 May;155:293-303.
Tayor SL, Ganti S, Bukanov NO, Chapman A, Fiehn O, Osier M, Kim K, Weiss RH. A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. American Journal of Physiology: Renal Physiology. 2010 298:909-922, with Editorial Forum
Weiss, RH. Invited editorial (Weiss: Editor-in-Chief): Why another cancer journal? Cancers, 1(1):1-2, 2009
Perroud, B., Ishimaru, T., Borowsky, A.D., Weiss, RH. Grade-dependent proteomic characterization of kidney cancer, Molecular and Cellular Proteomics, May; 8(5):971-85, 2009
Kim, K.M., Aronov, P.A, Zakharkin, S.O., Anderson, D., Perroud, B., Weiss, RH., Urine metabolomic analysis for kidney cancer detection and biomarker discovery, Molecular and Cellular Proteomics, Mar; 8(3):558-70, 2009
Liu , J.-Y. Park, S.-H., Morisseau , C., Hwang, S. H., Hammock, B., Weiss, RH., Sorafenib Has she Inhibitory Activity Which Contributes to Its Effect Profile in vivo, Molecular Cancer Therapeutics, 2009 Aug; 8(8):2193-203, 2009
Park SH, Wang X, Liu R, Lam KS, Weiss RH. High throughput screening of a small molecule one-bead-one-compound combinatorial library to identify attenuators of p21 as chemotherapy sensitizers, Cancer Biology Therapy 2008 Dec 26;712.